Details of the Drug

General Information of Drug (ID: DMO4MHA)

Drug Name

PHY-906

Indication

Disease Entry	ICD 11	Status	REF
Hepatocellular carcinoma	2C12.02	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer. Cancer Chemother Pharmacol. 2014 Feb;73(2):373-80.